Stay updated with breaking news from Arsalan Azad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Demand for COVID pills is set to make Pfizer Inc.’s Paxlovid among the fastest-selling treatments of all time, with revenue of almost $24 billion expected in 2022, according to a
Overall sales of Covid-19 pills are expected to hit US$32.5 billion (S$44.54 billion) this year. . Read more at straitstimes.com.
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
As richer nations rush to purchase supplies, while less affluent countries will have to wait until early 2023 for generic-drug companies to produce large quantities, an analysis shows.
Pfizer is set to dominate a $20 billion market for Covid pills next year as richer nations rush to purchase supplies, while less affluent countries will